Publication | Closed Access

Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis

ThrombopoiesisThrombosisHemostatic EffectsCardiovascular DiseaseBlood PlateletAtherosclerosisMedicineCoronary ThrombosisHematologyFibrinolysisPharmacotherapyPlatelet AntagonistPharmacologyAnticoagulantCardiologyDose-dependent Thrombolysis